Ignite Creation Date:
2025-12-24 @ 1:13 PM
Ignite Modification Date:
2026-02-22 @ 5:22 PM
Study NCT ID:
NCT00482495
Status:
COMPLETED
Last Update Posted:
2011-05-11
First Post:
2007-06-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bevacizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma
Sponsor:
Mayo Clinic
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Multiple Myeloma and Plasma Cell Neoplasm | View |